Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.

Dean FollmannAllyson MatejaMichael P FayCraig A MagaretYunda HuangYouyi FongHeather AngierMartha NasonCynthia L GayKaren KotloffWayne WooIksung ChoLisa M Dunkle

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

NVX-CoV2373 has high initial efficacy against pre-Delta and Delta strains of COVID-19 with little evidence of waning for pre-Delta strains through 90 days and moderate waning against Delta strains over 180 days.

Keyphrases

sars cov
coronavirus disease
escherichia coli
respiratory syndrome coronavirus
high intensity